Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Director/PDMR Shareholding

27 Sep 2007 15:20

F&C Private Equity Trust PLC27 September 2007 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer F&C Private Equity Trust plc 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) Related to (iii) 3. Name of person discharging managerial responsibilities/director Elizabeth Kennedy 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person N/A 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest Beneficial interest 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares Ordinary A shares and Ordinary B shares 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them As 4 8 State the nature of the transaction Market Purchase 9. Number of shares, debentures or financial instruments relating to sharesacquired 5,000 A shares 5,000 B shares 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.01% A shares 0.01% B shares 11. Number of shares, debentures or financial instruments relating to sharesdisposed N/A 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) N/A 13. Price per share or value of transaction 0.3715 (A shares) 1.768 (B shares) 14. Date and place of transaction 27/09/07 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 5,000 A shares (0.01%) 15,000 B shares (0.02%) 16. Date issuer informed of transaction 27/09/07 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 18. Period during which or date on which it can be exercised 19. Total amount paid (if any) for grant of the option 20. Description of shares or debentures involved (class and number) 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 22. Total number of shares or debentures over which options held followingnotification 23. Any additional information 24. Name of contact and telephone number for queries Philip Rorke 0207 628 8000 Name and signature of duly authorised officer of issuer responsible for makingnotification Martin Cassels Date of notification 27 September 2007 END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Sep 20063:35 pmRNSNet Asset Value(s)
6th Sep 20063:28 pmRNSNet Asset Value(s)
5th Sep 20064:13 pmRNSNet Asset Value(s)
4th Sep 20064:26 pmRNSPortfolio Update
4th Sep 20063:33 pmRNSNet Asset Value(s)
1st Sep 20062:33 pmRNSNet Asset Value(s)
31st Aug 20063:26 pmRNSNet Asset Value(s)
30th Aug 20064:21 pmRNSNet Asset Value(s)
25th Aug 20062:26 pmRNSNet Asset Value(s)
24th Aug 20064:23 pmRNSNet Asset Value(s)
23rd Aug 20063:40 pmRNSNet Asset Value(s)
22nd Aug 20064:04 pmRNSNet Asset Value(s)
21st Aug 20063:40 pmRNSNet Asset Value(s)
18th Aug 20061:55 pmRNSNet Asset Value(s)
18th Aug 200610:58 amRNSHolding(s) in Company
17th Aug 20063:07 pmRNSNet Asset Value(s)
16th Aug 20062:59 pmRNSNet Asset Value(s)
15th Aug 20063:33 pmRNSNet Asset Value(s)
11th Aug 20063:54 pmRNSNet Asset Value(s)
10th Aug 20063:48 pmRNSNet Asset Value(s)
9th Aug 20062:54 pmRNSNet Asset Value(s)
8th Aug 20063:26 pmRNSNet Asset Value(s)
7th Aug 20064:05 pmRNSNet Asset Value(s)
4th Aug 20064:09 pmRNSNet Asset Value(s)
2nd Aug 20064:39 pmRNSPortfolio Update
2nd Aug 20064:39 pmRNSTop 10 Holdings
2nd Aug 20063:23 pmRNSNet Asset Value(s)
1st Aug 20064:12 pmRNSNet Asset Value(s)
31st Jul 20063:23 pmRNSNet Asset Value(s)
28th Jul 20063:55 pmRNSNet Asset Value(s)
27th Jul 20063:38 pmRNSNet Asset Value(s)
26th Jul 20062:58 pmRNSNet Asset Value(s)
25th Jul 20062:52 pmRNSNet Asset Value(s)
24th Jul 20063:22 pmRNSNet Asset Value(s)
20th Jul 20062:05 pmRNSNet Asset Value(s)
19th Jul 20063:41 pmRNSNet Asset Value(s)
18th Jul 20063:02 pmRNSNet Asset Value(s)
17th Jul 20063:26 pmRNSNet Asset Value(s)
14th Jul 20063:50 pmRNSNet Asset Value(s)
13th Jul 20063:36 pmRNSNet Asset Value(s)
12th Jul 20063:19 pmRNSNet Asset Value(s)
10th Jul 20064:01 pmRNSNet Asset Value(s)
7th Jul 20064:12 pmRNSNet Asset Value(s)
5th Jul 20063:02 pmRNSNet Asset Value(s)
4th Jul 20062:45 pmRNSNet Asset Value(s)
3rd Jul 20064:44 pmRNSHolding(s) in Company
3rd Jul 20064:16 pmRNSNet Asset Value(s)
30th Jun 20063:09 pmRNSNet Asset Value(s)
29th Jun 20063:46 pmRNSNet Asset Value(s)
28th Jun 200612:49 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.